FDA Imposes Approval Requirement for Radiology AI and Mastercard Partners with Alchemy
The FDA tied the revenue generation of radiology AI software to premarket clearance, while Mastercard and Alchemy developed a payment solution for AI agents.
The US Food and Drug Administration has enacted its final decision maintaining the mandatory pre-clearance requirement for certain AI-powered radiology software to engage in commercial operations.
Details of the FDA Decision
The US Food and Drug Administration continues to enforce a strict regulatory review mechanism for any new radiology algorithm to generate revenue in the United States.
Rejection of Harrison.ai Application
The enacted final decision confirms the official rejection of a previous exemption application filed by health AI company Harrison.ai.
Cancer and Imaging Tools
Four types of software that detect cancer lesions, analyze medical images, and alert clinicians to urgent findings fall under this regulation.
Mastercard and Alchemy Partnership
Mastercard and Alchemy announced a new payment option featuring AgentCard and Mastercard Agent Pay technologies to enable AI agents to make secure purchases.